Financial Tribune – Over the past two decades, the Islamic Republic of Iran has made significant progress in the health and medical sector, expanding both in market size and coverage.
The country’s ever-growing medical innovation ecosystem is supported by ongoing policy framework developments, incentives and regulatory bodies.
In addition, the emergence and development of the complex, high-tech biopharma sector of Iran host several successful local export firms, according to the “Global Innovation Index 2019” report published by Cornell University, INSEAD, and the World Intellectual Property Organization, in partnership with other organizations and institutions.
The evolving pro-innovation ecosystem of the health sector in Iran has achieved effective policy and regulatory synergies, and supported the supply and demand side of medical innovation.
Demand-side innovation has paved the way for advanced endogenous medical innovations in Iran while, historically, conventional medical solutions were not easily accessible due to sanctions or affordability.